<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862346</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1319</article-id><article-id pub-id-type="other">EPV0668</article-id><article-id pub-id-type="pii">S0924933824013191</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Benzodiazepines and risk of dementia &#x02013; Is there a reason for alarm?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Andrade</surname><given-names>R. P. L.</given-names></name><xref rid="aff2937" ref-type="aff"/><xref rid="cor1171" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Castro</surname><given-names>N.</given-names></name><xref rid="aff2937" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Vaz</surname><given-names>R.</given-names></name><xref rid="aff2937" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Martins</surname><given-names>J.</given-names></name><xref rid="aff2937" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Abreu</surname><given-names>J.</given-names></name><xref rid="aff2937" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>E.</given-names></name><xref rid="aff2937" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>I.</given-names></name><xref rid="aff2937" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Cunha</surname><given-names>F.</given-names></name><xref rid="aff2937" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Afonso</surname><given-names>H.</given-names></name><xref rid="aff2937" ref-type="aff"/></contrib></contrib-group><aff id="aff2937"><institution>Centro Hospitalar Tondela-Viseu
</institution>, <city>Viseu</city>, <country>Portugal</country></aff><author-notes><corresp id="cor1171"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1294">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S636</fpage><lpage>S637</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824013191a.pdf"/><abstract><sec id="sec7039"><title>Introduction</title><p>The population ageing is a reality associated with an increase in prevalence of Dementia. The use of benzodiazepines is often postulated as a risk factor in these syndromes.</p><p>Contrary to recommendations for its short-time use, long-term and chronic use are common, with an estimated 8,7% of elderly people in the US taking benzodiazepines.</p></sec><sec id="sec7040"><title>Objectives</title><p>To clarify the most recent evidence on the use of benzodiazepines and the risk of developing dementia.</p></sec><sec id="sec7041"><title>Methods</title><p>Non-systematic review of literature, using PubMed as database and filtering the results for meta-analysis.</p></sec><sec id="sec7042"><title>Results</title><p>Four articles were included in this review.</p><p>Zhong G et al. concluded that risk of dementia increased in consumers of benzodiazepines and it was associated with higher doses.</p><p>In turn, AlDawasari A et al., when trying to clarify the use of different sedative-hypnotic drugs, found and increased risk with the consumption of benzodiazepines. After exclusion of articles with confounders and adjustment for protopathic bias, the risk was not maintained.</p><p>Lucchetta RC et al. concluded that the risk exists but without inferring differences between doses or duration of action.</p><p>Finally, Penninkilampi R e Eslick GD investigated this association, after controlling for the protopathic bias, concluding, contrary to AlDawasari et al., that the association benzodiazepines consumption and dementia do not result from this bias.</p></sec><sec id="sec7043"><title>Conclusions</title><p>We cannot draw robust and concrete conclusions between benzodiazepines consumption and the pathogenesis of dementia because not only is the literature limited, but results are also heterogeneous.</p><p>
However, these prescriptions must be carried out cautiously, especially in the elderly, due to the known adverse effects associated with them.</p></sec><sec id="sec7044"><title>Disclosure of Interest</title><p>None Declared
</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>